After Hours
The risks associated with pre-market and after-hours trading may be slightly higher than the regular market hours. The reason is that extended-hours trading may result in wider spreads for particular security due to lower liquidity and higher volatility as issuers often announce critical financial information outside regular trading hours.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stocks Info
Charles River Laboratories International Inc. is listed on the NYSE as a member of the Healthcare sector and is a part of the Diagnostics & Research industry. The current market capitalization of Charles River Laboratories International Inc. is $12.03B. A total of 0.65 million shares were traded on the day, compared to an average of 507.70K shares.
In the most recent transaction, MASSARO GEORGE sold 332 shares of CRL for 235.62 per share on May 15 ’24. After the transaction, the Director now owns 5,855 company shares. In a previous transaction on May 10 ’24, LaPlume Joseph W sold 1,304 shares at 226.97 per share. CRL shares that EVP, Corp Strategy & Develop owns now total 23,276.
Among the insiders who sold shares, Knell Michael Gunnar disposed of 808 shares on Mar 08 ’24 at a per-share price of $267.52. This resulted in the CSVP&Chief Accounting Officer holding 7,024 shares of CRL after the transaction. In another insider transaction, Knell Michael Gunnar sold 2,750 shares at $261.05 per share on Mar 04 ’24. Company shares held by the CSVP&Chief Accounting Officer now total 7,832.
Though price targets are rarely accurate, they can exert some influence from time to time and were often accepted as valuable by the market. In terms of 52-week highs and lows, CRL has a high of $275.00 and a low of $161.65.
As of this writing, CRL has an earnings estimate of $2.39 per share for the current quarter. EPS was calculated based on a consensus of 16.0 estimates, with a high estimate of $2.43 per share and a lower estimate of $2.36. The company reported an EPS of $2.69 in the last quarter
Balance Sheet Annually/Quarterly
A balance sheet is a report that shows the company’s assets and liabilities. In addition, it shows how much equity investors have invested in the company. Investors can determine the company’s prospects by calculating its financial ratios based on this information. CRL’s latest balance sheet shows that the firm has $241.21M in Cash & Short Term Investments as of fiscal 2021. There were $2.92B in debt and $1.03B in liabilities at the time. Its Book Value Per Share was $70.67, while its Total Shareholder’s Equity was $2.59B.
Analysts Opinion
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for CRL is Buy with a score of 4.00.
